Revenue
$17.68B
Fiscal year ended 2025-12-31Operating income
$6.02B
Fiscal year ended 2025-12-31Free cash flow
$2.60B
Fiscal year ended 2025-12-31TEXAS INSTRUMENTS INC (TXN) reported revenue of $17.68B and net income of $5.00B for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from TEXAS INSTRUMENTS INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Semiconductors & Related Devices.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.68B | $15.64B | $17.52B | $20.03B | $18.34B | $14.46B | $14.38B | $15.78B | $14.96B | $13.37B |
| Cost of revenue | $7.60B | $6.55B | $6.50B | $6.26B | $5.97B | $5.19B | $5.22B | $5.51B | $5.35B | $5.11B |
| Gross profit | $10.08B | $9.09B | $11.02B | $13.77B | $12.38B | $9.27B | $9.16B | $10.28B | $9.61B | $8.26B |
| Operating income | $6.02B | $5.46B | $7.33B | $10.14B | $8.96B | $5.89B | $5.72B | $6.71B | $6.08B | $4.86B |
| Net income | $5.00B | $4.80B | $6.51B | $8.75B | $7.77B | $5.60B | $5.02B | $5.58B | $3.68B | $3.60B |
| Research & development | $2.08B | $1.96B | $1.86B | $1.67B | $1.55B | $1.53B | $1.54B | $1.56B | $1.51B | $1.36B |
| Weighted-average diluted shares | shares 913.00M | shares 919.00M | shares 916.00M | shares 926.00M | shares 936.00M | shares 933.00M | shares 952.00M | shares 990.00M | shares 1.01B | shares 1.02B |
| Pretax income | $5.71B | $5.45B | $7.42B | $10.03B | $8.92B | $6.02B | $5.73B | $6.69B | $6.08B | $4.93B |
| Income tax expense | $709.00M | $654.00M | $908.00M | $1.28B | $1.15B | $422.00M | $711.00M | $1.11B | $2.40B | $1.34B |
| Diluted EPS | $5.45 | $5.20 | $7.07 | $9.41 | $8.26 | $5.97 | $5.24 | $5.59 | $3.61 | $3.48 |
| Selling, general & administrative | $1.86B | $1.79B | $1.82B | $1.70B | $1.67B | $1.62B | $1.64B | $1.68B | $1.69B | $1.74B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $3.22B | $3.20B | $2.96B | $3.05B | $4.63B | $3.11B | $2.44B | $2.44B | $1.66B | $1.15B |
| Total assets | $34.58B | $35.51B | $32.35B | $27.21B | $24.68B | $19.35B | $18.02B | $17.14B | $17.64B | $16.43B |
| Current assets | $13.75B | $15.03B | $15.12B | $14.02B | $13.68B | $10.24B | $8.76B | $8.10B | $8.73B | $7.46B |
| Total liabilities | $18.31B | $18.61B | $15.45B | $12.63B | $11.34B | $10.16B | $9.11B | $8.14B | $7.30B | $5.96B |
| Current liabilities | $3.16B | $3.64B | $3.32B | $2.98B | $2.57B | $2.39B | $2.12B | $2.47B | $2.26B | $2.26B |
| Total equity incl. NCI | $16.27B | $16.90B | $16.90B | $14.58B | $13.33B | $9.19B | $8.91B | $8.99B | $10.34B | $10.47B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $4.80B | $4.53B | $4.00B | $2.76B | $1.91B | $1.96B | $2.00B | $2.22B | $1.96B | $1.79B |
| Accounts receivable | $1.96B | $1.72B | $1.79B | $1.90B | $1.70B | $1.41B | $1.07B | $1.21B | $1.28B | $1.27B |
| Goodwill | $4.33B | $4.36B | $4.36B | $4.36B | $4.36B | $4.36B | $4.36B | $4.36B | $4.36B | $4.36B |
| Long-term debt | $13.55B | $12.85B | $10.62B | $8.24B | $7.24B | $6.25B | $5.30B | $4.32B | $3.58B | $2.98B |
| Accounts payable | $756.00M | $820.00M | $802.00M | $851.00M | $571.00M | $415.00M | $388.00M | $478.00M | $466.00M | $396.00M |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $7.15B | $6.32B | $6.42B | $8.72B | $8.76B | $6.14B | $6.65B | $7.19B | $5.36B | $4.61B |
| Capital expenditures | $4.55B | $4.82B | $5.07B | $2.80B | $2.46B | $649.00M | $847.00M | $1.13B | $695.00M | $531.00M |
| Investing cash flow | -$1.44B | -$3.20B | -$4.36B | -$3.58B | -$4.10B | -$922.00M | -$1.92B | -$78.00M | -$1.13B | -$650.00M |
| Financing cash flow | -$5.69B | -$2.88B | -$2.14B | -$6.72B | -$3.14B | -$4.55B | -$4.73B | -$6.33B | -$3.73B | -$3.81B |
| Net change in cash | $25.00M | $236.00M | -$86.00M | -$1.58B | $1.52B | $670.00M | -$1.00M | $782.00M | $502.00M | $154.00M |
| Stock-based compensation | $419.00M | $387.00M | $362.00M | $289.00M | $230.00M | $224.00M | $217.00M | $232.00M | $242.00M | $252.00M |
| Common dividends paid | $5.00B | $4.80B | $4.56B | $4.30B | $3.89B | $3.43B | $3.01B | $2.56B | $2.10B | $1.65B |
| Common share repurchases | $1.48B | $929.00M | $293.00M | $3.62B | $527.00M | $2.55B | $2.96B | $5.10B | $2.56B | $2.13B |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $2.60B | $1.50B | $1.35B | $5.92B | $6.29B | $5.49B | $5.80B | $6.06B | $4.67B | $4.08B |
| Gross margin | 57.0% | 58.1% | 62.9% | 68.8% | 67.5% | 64.1% | 63.7% | 65.1% | 64.3% | 61.8% |
| Operating margin | 34.1% | 34.9% | 41.8% | 50.6% | 48.8% | 40.8% | 39.8% | 42.5% | 40.7% | 36.3% |
| FCF margin | 14.7% | 9.6% | 7.7% | 29.6% | 34.3% | 38.0% | 40.3% | 38.4% | 31.2% | 30.5% |
| SBC / revenue | 2.4% | 2.5% | 2.1% | 1.4% | 1.3% | 1.5% | 1.5% | 1.5% | 1.6% | 1.9% |
| Current ratio | 4.35x | 4.12x | 4.55x | 4.70x | 5.33x | 4.28x | 4.13x | 3.27x | 3.87x | 3.29x |
| Revenue YoY growth | 13.0% | -10.7% | -12.5% | 9.2% | 26.9% | 0.5% | -8.9% | 5.5% | 11.9% | Unavailable |
| Net margin | 28.3% | 30.7% | 37.2% | 43.7% | 42.4% | 38.7% | 34.9% | 35.4% | 24.6% | 26.9% |
| R&D / revenue | 11.8% | 12.5% | 10.6% | 8.3% | 8.5% | 10.6% | 10.7% | 9.9% | 10.1% | 10.1% |
| CapEx / revenue | 25.7% | 30.8% | 28.9% | 14.0% | 13.4% | 4.5% | 5.9% | 7.2% | 4.6% | 4.0% |
| Long-term debt / equity | 0.83x | 0.76x | 0.63x | 0.56x | 0.54x | 0.68x | 0.60x | 0.48x | 0.35x | 0.28x |
| Effective tax rate | 12.4% | 12.0% | 12.2% | 12.8% | 12.9% | 7.0% | 12.4% | 16.5% | 39.4% | 27.1% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open TXN in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-07-24View SEC filing
10-Q · Filed 2026-04-24View SEC filing
10-K · Filed 2026-02-06View SEC filing
10-Q · Filed 2025-10-23View SEC filing
10-Q · Filed 2025-07-29View SEC filing
10-Q · Filed 2025-04-24View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.